A shift toward personalized medicine in pneumonia management would involve refining the diagnostic categories to include viral pneumonia, bacterial pneumonia, and noninfectious respiratory disease.
Use of rapid polymerase chain reaction-based diagnostic tests for MRSA significantly reduced the use of vancomycin and linezolid in patients who were mechanically ventilated with suspected pneumonia at risk for MRSA.
